Status:
UNKNOWN
Intraoperative ICG Fluorescence Imaging for Peritoneal Carcinomatosis Detection
Lead Sponsor:
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Conditions:
Peritoneal Carcinomatosis
Gastric Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background. Peritoneal carcinomatosis is a frequent and deadly localization of gastric cancer. Available imaging techniques have a low accuracy in detecting small peritoneal nodules, and direct laparo...
Eligibility Criteria
Inclusion
- Age of ≥18years
- Ability to provide written informed consent
- Histologically confirmed gastric adenocarcinoma or oesophago-gastric junction adenocarcinoma Siewert 2 and 3
- cT\>1
- cM0 (clinical staging: no metastases)
- Staging laparoscopy is indicated by the internal work-up protocol
- Staging laparoscopy is in accordance with NCCN (National Comprehensive Cancer Network) guidelines
Exclusion
- Pregnancy
- Iodine allergy/sensibility
- Clinical P1 (defined as high probability of peritoneal carcinomatosis at imaging)
- Investigator judgement that the patient should not participate for any reason
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04352894
Start Date
September 1 2020
End Date
September 1 2021
Last Update
April 20 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.